Shire Mergers and Acquisitions Summary

Life Science Company

Shire has acquired 15 companies of its own, including 6 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 3 assets.

Shire’s largest acquisition to date was in 2016, when it acquired Baxalta for $32.0B. Shire has acquired in 7 different US states, and 4 countries. The Company’s most targeted sectors include life science (94%) and healthcare services (7%).

Join Mergr and gain access to Shire’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity18
    • M&A Buy Activity15
    • M&A Sell Activity3
  • Total Sectors Invested 2
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 6
  • M&A Advisors 11

Shire plc

5 Riverwalk Citywest Business Campus,
Dublin, 24
Ireland,
+353 1 429 7700
www.shire.com

Shire plc is a global specialty biopharmaceutical company. Shire plc strive to develop best-in-class therapies across a core of rare disease areas including hematology, immunology, genetic diseases, neuroscience, and internal medicine with growing therapeutic areas in ophthalmics and oncology. Our diversified capabilities enable us to reach patients in more than 100 countries who are struggling to live their lives to the fullest.


M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.4/yr) # 13 1 - 1 - - 15
vol $17.4B $32.0B $49.4B
Sell (0.4/yr) # 1 1 1 - - - 3
  18

Most Recent M&A

Company Date Value Type
sanaplasma AG 2018-09-06 - Add-on Acquisition
, Switzerland · www.sanaplasma.com
Shire plc - MRT platform 2017-01-04 - Divestiture
Dublin, Ireland
Shire Plc - Pre-clinical Programmes 2016-07-20 - Divestiture
, Ireland
Baxalta, Inc. 2016-01-11 32.0B USD Merger
Deerfield, Illinois · www.baxalta.com
Dyax Corp. 2015-11-02 5.9B USD Add-on Acquisition
Burlington, Massachusetts · www.dyax.com
Foresight Biotherapeutics, Inc. 2015-08-03 300M USD Add-on Acquisition
New York, New York · www.foresightbio.com
Meritage Pharma, Inc. 2015-02-24 70M USD Add-on Acquisition
San Diego, California · www.meritagepharma.com
NPS Pharmaceuticals, Inc. 2015-02-21 5.2B USD Add-on Acquisition
Bedminster, New Jersey · www.npsp.com
Lumena Pharmaceuticals, Inc. 2014-05-12 260M USD Add-on Acquisition
San Diego, California · www.lumenapharma.com
Fibrotech Therapeutics Pty Ltd. 2014-05-02 75M USD Add-on Acquisition
Wonga Park, Australia
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Shire Regenerative Medicine, Inc.    - Smith & Nephew - Dermagraft Product 2006-05-31 2
Westport, Connecticut , United Kingdom
Shire Regenerative Medicine, Inc.    - Smith & Nephew - TransCyte Product Line 2006-05-31 1
Westport, Connecticut , United Kingdom

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 14 (93%) 49.4B (100%) 2 (67%) -
Healthcare Services 1 (7%) - - -
Information Technology - - 1 (33%) -
Total 15 $49.4B 3 -

By Geo

State/Country Buy Value Sell Value
United States 12 49.2B 1 -
  California 4 815M - -
  Massachusetts 3 5.9B 1 -
  Pennsylvania 1 4.2B - -
  New York 1 300M - -
  New Jersey 1 5.2B - -
  Illinois 1 32.0B - -
  Connecticut 1 750M - -
Ireland - - 2 -
Australia 1 75M - -
Switzerland 1 - - -
United Kingdom 1 186M - -
Domestic - - 2 (67%) -
Cross-border 15 (100%) 49.4B (100%) 1 (33%) -
Total 15 $49.4B 3 -

Top M&A Advisors

Financial Deals
Barclays Investment Bank
3
Morgan Stanley
3
Deutsche Bank Corporate & Investment Banking
2
Legal Deals
Davis Polk & Wardwell LLP
4
Slaughter and May
2
Ropes & Gray LLP
2

Deal Values

buy # Total
> $1B 4 $47.3B
$100M to $1B 6 $2.0B
< $100M 2 $145M
TOTAL $49.4B
Largest Baxalta, Inc.
$32.0B (2016-01-11)

M&A Connections

Deals %
Acquired from
PE Firm(s)
67%
2 67%
Strategic(s)
33%
1 33%
Divested to
Strategic(s)
100%
3 100%

 Subscribe to unlock this and 155,724
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.0K Private Equity Firms
  • 144K M&A Transactions
  • 152K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.1K M&A Advisors
    (Investment Banks and Law Firms)
  • 45K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.